Skip to content

Clinical trials

Phase 3 Lung Diseases trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 3 Country / region: Spain Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20121
20131
20145
20162
20171
20181
20193
20201
20211
20221
20232
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting9
Terminated4
Active, not recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca9
Fundación GECP2
Pfizer2
United Therapeutics2
Aeris Therapeutics1
Bayer1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Grifols Therapeutics LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases28
Respiratory Tract Diseases17
Lung Diseases, Obstructive9
Bronchial Diseases8
Carcinoma, Non-Small-Cell Lung8
Asthma7
Lung Neoplasms5
Pulmonary Disease, Chronic Obstructive5
COVID-194
Respiratory Tract Infections4

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.